Cellular Genomics Achieves Key Milestone in Joint Kinase Discovery Program

Cellular Genomics (CGI), a chemical genetics based drug discovery and development company, has announced the completion of a key performance milestone in its joint kinase discovery program with Serono. Under the alliance, CGI has been applying its proprietary chemical genetics Analog Sensitive Kinase (ASKA) technology to a number of target kinases selected by Serono. The milestone relates to the successful development of CGI's unique in vivo models for kinase drug discovery. The completion of the milestone entitles CGI to a performance payment.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/02-15-2005/0003022087&EDATE=)